Structure

Physi-Chem Properties

Molecular Weight:  318.22
Volume:  341.348
LogP:  2.128
LogD:  1.516
LogS:  -3.498
# Rotatable Bonds:  1
TPSA:  57.53
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.73
Synthetic Accessibility Score:  6.085
Fsp3:  0.85
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.688
MDCK Permeability:  2.268613752676174e-05
Pgp-inhibitor:  0.032
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.818
30% Bioavailability (F30%):  0.056

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.943
Plasma Protein Binding (PPB):  81.8726806640625%
Volume Distribution (VD):  1.505
Pgp-substrate:  16.15689468383789%

ADMET: Metabolism

CYP1A2-inhibitor:  0.008
CYP1A2-substrate:  0.94
CYP2C19-inhibitor:  0.034
CYP2C19-substrate:  0.815
CYP2C9-inhibitor:  0.082
CYP2C9-substrate:  0.074
CYP2D6-inhibitor:  0.009
CYP2D6-substrate:  0.11
CYP3A4-inhibitor:  0.904
CYP3A4-substrate:  0.573

ADMET: Excretion

Clearance (CL):  4.11
Half-life (T1/2):  0.655

ADMET: Toxicity

hERG Blockers:  0.008
Human Hepatotoxicity (H-HT):  0.103
Drug-inuced Liver Injury (DILI):  0.076
AMES Toxicity:  0.15
Rat Oral Acute Toxicity:  0.579
Maximum Recommended Daily Dose:  0.178
Skin Sensitization:  0.034
Carcinogencity:  0.626
Eye Corrosion:  0.189
Eye Irritation:  0.192
Respiratory Toxicity:  0.938

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472484

Natural Product ID:  NPC472484
Common Name*:   PYLFLALBRCJWJW-ZLARMEDBSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  PYLFLALBRCJWJW-ZLARMEDBSA-N
Standard InCHI:  InChI=1S/C20H30O3/c1-13-16(22)19-9-5-14-17(2,12-21)7-4-8-18(14,3)15(19)6-10-20(13,23)11-19/h6,13-14,21,23H,4-5,7-12H2,1-3H3/t13-,14+,17-,18+,19+,20-/m0/s1
SMILES:  OC[C@]1(C)CCC[C@@]2([C@@H]1CC[C@]13C2=CC[C@](C1)([C@H](C3=O)C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3426492
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0003782] Kaurane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32442 jungermannia fauriana Species Jungermanniaceae Eukaryota n.a. Guangxi Zhuang Autonomous Region, China n.a. PMID[25856683]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2410 Cell Line NCI-H1299 Homo sapiens IC50 > 50000.0 nM PMID[479359]
NPT114 Cell Line LoVo Homo sapiens IC50 > 50000.0 nM PMID[479359]
NPT111 Cell Line K562 Homo sapiens IC50 > 50000.0 nM PMID[479359]
NPT90 Cell Line DU-145 Homo sapiens IC50 > 50000.0 nM PMID[479359]
NPT858 Cell Line LNCaP Homo sapiens IC50 > 50000.0 nM PMID[479359]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 > 50000.0 nM PMID[479359]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 50000.0 nM PMID[479359]
NPT27 Others Unspecified IC50 > 50000.0 nM PMID[479359]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472484 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC472482
1.0 High Similarity NPC472481
0.9639 High Similarity NPC472483
0.963 High Similarity NPC472480
0.9405 High Similarity NPC328313
0.9398 High Similarity NPC472491
0.9398 High Similarity NPC472494
0.9294 High Similarity NPC472475
0.9294 High Similarity NPC472477
0.9205 High Similarity NPC472485
0.907 High Similarity NPC76879
0.9059 High Similarity NPC472493
0.9048 High Similarity NPC474218
0.9036 High Similarity NPC472492
0.8966 High Similarity NPC472476
0.8953 High Similarity NPC53911
0.8941 High Similarity NPC472479
0.8929 High Similarity NPC59453
0.8929 High Similarity NPC221758
0.8929 High Similarity NPC82902
0.8916 High Similarity NPC151519
0.8851 High Similarity NPC472489
0.8721 High Similarity NPC145879
0.8721 High Similarity NPC469994
0.8721 High Similarity NPC20688
0.8721 High Similarity NPC474778
0.8721 High Similarity NPC474733
0.8721 High Similarity NPC31564
0.8721 High Similarity NPC474732
0.8721 High Similarity NPC51014
0.8706 High Similarity NPC329043
0.8706 High Similarity NPC58841
0.8706 High Similarity NPC321187
0.8706 High Similarity NPC161423
0.8706 High Similarity NPC227064
0.869 High Similarity NPC193347
0.8636 High Similarity NPC310010
0.8636 High Similarity NPC326627
0.8636 High Similarity NPC2983
0.8636 High Similarity NPC32830
0.8636 High Similarity NPC477943
0.8636 High Similarity NPC474245
0.8621 High Similarity NPC475740
0.8621 High Similarity NPC96496
0.8621 High Similarity NPC317590
0.8621 High Similarity NPC58063
0.8605 High Similarity NPC469948
0.8571 High Similarity NPC14151
0.8571 High Similarity NPC469599
0.8556 High Similarity NPC474807
0.8556 High Similarity NPC233118
0.8539 High Similarity NPC320026
0.8539 High Similarity NPC171441
0.8506 High Similarity NPC155011
0.8506 High Similarity NPC472488
0.8488 Intermediate Similarity NPC237712
0.8488 Intermediate Similarity NPC144258
0.8488 Intermediate Similarity NPC214043
0.8488 Intermediate Similarity NPC85774
0.8452 Intermediate Similarity NPC472478
0.8444 Intermediate Similarity NPC154101
0.8427 Intermediate Similarity NPC268406
0.8427 Intermediate Similarity NPC1015
0.8427 Intermediate Similarity NPC31985
0.8427 Intermediate Similarity NPC119416
0.8427 Intermediate Similarity NPC472971
0.8427 Intermediate Similarity NPC26959
0.8427 Intermediate Similarity NPC472970
0.8427 Intermediate Similarity NPC186688
0.8427 Intermediate Similarity NPC476733
0.8427 Intermediate Similarity NPC215029
0.8409 Intermediate Similarity NPC90652
0.8404 Intermediate Similarity NPC110149
0.8391 Intermediate Similarity NPC471224
0.8372 Intermediate Similarity NPC477852
0.8372 Intermediate Similarity NPC278648
0.8372 Intermediate Similarity NPC476082
0.837 Intermediate Similarity NPC263347
0.8352 Intermediate Similarity NPC470375
0.8352 Intermediate Similarity NPC470376
0.8333 Intermediate Similarity NPC69622
0.8333 Intermediate Similarity NPC474113
0.8333 Intermediate Similarity NPC48010
0.8333 Intermediate Similarity NPC215843
0.8315 Intermediate Similarity NPC471722
0.8315 Intermediate Similarity NPC328539
0.8315 Intermediate Similarity NPC474677
0.8315 Intermediate Similarity NPC193360
0.8315 Intermediate Similarity NPC470417
0.8315 Intermediate Similarity NPC471724
0.8295 Intermediate Similarity NPC473168
0.8295 Intermediate Similarity NPC475022
0.8295 Intermediate Similarity NPC327115
0.8295 Intermediate Similarity NPC89077
0.8295 Intermediate Similarity NPC222613
0.8295 Intermediate Similarity NPC118648
0.828 Intermediate Similarity NPC49371
0.8276 Intermediate Similarity NPC473246
0.8276 Intermediate Similarity NPC472265
0.8261 Intermediate Similarity NPC292793
0.8261 Intermediate Similarity NPC111015
0.8256 Intermediate Similarity NPC110780
0.8256 Intermediate Similarity NPC46881
0.8242 Intermediate Similarity NPC475806
0.8235 Intermediate Similarity NPC2482
0.8222 Intermediate Similarity NPC474570
0.8222 Intermediate Similarity NPC309603
0.8222 Intermediate Similarity NPC473999
0.8222 Intermediate Similarity NPC54689
0.8214 Intermediate Similarity NPC477522
0.8214 Intermediate Similarity NPC82635
0.8211 Intermediate Similarity NPC83709
0.8211 Intermediate Similarity NPC154072
0.8202 Intermediate Similarity NPC474684
0.8202 Intermediate Similarity NPC142361
0.8202 Intermediate Similarity NPC165895
0.8202 Intermediate Similarity NPC136548
0.8202 Intermediate Similarity NPC93778
0.8193 Intermediate Similarity NPC96319
0.8191 Intermediate Similarity NPC107243
0.8191 Intermediate Similarity NPC18509
0.8191 Intermediate Similarity NPC190554
0.8191 Intermediate Similarity NPC57416
0.8182 Intermediate Similarity NPC470574
0.8182 Intermediate Similarity NPC202868
0.8182 Intermediate Similarity NPC474083
0.8182 Intermediate Similarity NPC102292
0.8172 Intermediate Similarity NPC271195
0.8172 Intermediate Similarity NPC472824
0.8161 Intermediate Similarity NPC477373
0.8161 Intermediate Similarity NPC474748
0.8152 Intermediate Similarity NPC66429
0.8152 Intermediate Similarity NPC250575
0.8152 Intermediate Similarity NPC243866
0.8152 Intermediate Similarity NPC152897
0.8152 Intermediate Similarity NPC472942
0.8144 Intermediate Similarity NPC191892
0.8144 Intermediate Similarity NPC117185
0.814 Intermediate Similarity NPC150506
0.814 Intermediate Similarity NPC147066
0.814 Intermediate Similarity NPC121984
0.8118 Intermediate Similarity NPC472490
0.8111 Intermediate Similarity NPC44181
0.8095 Intermediate Similarity NPC198968
0.8095 Intermediate Similarity NPC318495
0.8095 Intermediate Similarity NPC155986
0.809 Intermediate Similarity NPC94666
0.809 Intermediate Similarity NPC94755
0.809 Intermediate Similarity NPC470955
0.809 Intermediate Similarity NPC72133
0.8085 Intermediate Similarity NPC477853
0.8085 Intermediate Similarity NPC155676
0.8068 Intermediate Similarity NPC180834
0.8068 Intermediate Similarity NPC25833
0.8068 Intermediate Similarity NPC33913
0.8065 Intermediate Similarity NPC196485
0.8065 Intermediate Similarity NPC8993
0.8065 Intermediate Similarity NPC245972
0.8061 Intermediate Similarity NPC137657
0.8046 Intermediate Similarity NPC328351
0.8046 Intermediate Similarity NPC310989
0.8046 Intermediate Similarity NPC260956
0.8046 Intermediate Similarity NPC212083
0.8043 Intermediate Similarity NPC23434
0.8043 Intermediate Similarity NPC212301
0.8043 Intermediate Similarity NPC185936
0.8043 Intermediate Similarity NPC262870
0.8043 Intermediate Similarity NPC131872
0.8043 Intermediate Similarity NPC272746
0.8043 Intermediate Similarity NPC86266
0.8043 Intermediate Similarity NPC168027
0.8043 Intermediate Similarity NPC110657
0.8043 Intermediate Similarity NPC473998
0.8041 Intermediate Similarity NPC87351
0.8041 Intermediate Similarity NPC477915
0.8041 Intermediate Similarity NPC185530
0.8023 Intermediate Similarity NPC26117
0.8022 Intermediate Similarity NPC275740
0.8022 Intermediate Similarity NPC86319
0.8022 Intermediate Similarity NPC474704
0.8022 Intermediate Similarity NPC475921
0.8021 Intermediate Similarity NPC15390
0.8021 Intermediate Similarity NPC144956
0.8 Intermediate Similarity NPC73064
0.8 Intermediate Similarity NPC291634
0.8 Intermediate Similarity NPC475894
0.8 Intermediate Similarity NPC298904
0.8 Intermediate Similarity NPC187376
0.8 Intermediate Similarity NPC159046
0.8 Intermediate Similarity NPC312215
0.8 Intermediate Similarity NPC233836
0.8 Intermediate Similarity NPC126815
0.8 Intermediate Similarity NPC138756
0.798 Intermediate Similarity NPC149047
0.798 Intermediate Similarity NPC257353
0.798 Intermediate Similarity NPC166607
0.7979 Intermediate Similarity NPC127063
0.7979 Intermediate Similarity NPC162001
0.7979 Intermediate Similarity NPC472932
0.7979 Intermediate Similarity NPC222845

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472484 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8929 High Similarity NPD4786 Approved
0.8916 High Similarity NPD3667 Approved
0.8706 High Similarity NPD3666 Approved
0.8706 High Similarity NPD3133 Approved
0.8706 High Similarity NPD3665 Phase 1
0.869 High Similarity NPD4223 Phase 3
0.869 High Similarity NPD4221 Approved
0.8636 High Similarity NPD4753 Phase 2
0.8556 High Similarity NPD4202 Approved
0.8506 High Similarity NPD3574 Clinical (unspecified phase)
0.8506 High Similarity NPD3618 Phase 1
0.8488 Intermediate Similarity NPD4197 Approved
0.8391 Intermediate Similarity NPD5329 Approved
0.837 Intermediate Similarity NPD4629 Approved
0.837 Intermediate Similarity NPD5210 Approved
0.8295 Intermediate Similarity NPD5205 Approved
0.8295 Intermediate Similarity NPD4689 Approved
0.8295 Intermediate Similarity NPD4690 Approved
0.8295 Intermediate Similarity NPD4693 Phase 3
0.8295 Intermediate Similarity NPD4138 Approved
0.8295 Intermediate Similarity NPD4688 Approved
0.8222 Intermediate Similarity NPD5328 Approved
0.8193 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.8191 Intermediate Similarity NPD4755 Approved
0.8161 Intermediate Similarity NPD4788 Approved
0.8152 Intermediate Similarity NPD6399 Phase 3
0.814 Intermediate Similarity NPD4692 Approved
0.814 Intermediate Similarity NPD4139 Approved
0.809 Intermediate Similarity NPD5280 Approved
0.809 Intermediate Similarity NPD5690 Phase 2
0.809 Intermediate Similarity NPD4694 Approved
0.8068 Intermediate Similarity NPD3668 Phase 3
0.8043 Intermediate Similarity NPD6079 Approved
0.8021 Intermediate Similarity NPD4700 Approved
0.8021 Intermediate Similarity NPD4696 Approved
0.8021 Intermediate Similarity NPD5285 Approved
0.8021 Intermediate Similarity NPD5286 Approved
0.8 Intermediate Similarity NPD6083 Phase 2
0.8 Intermediate Similarity NPD6084 Phase 2
0.7938 Intermediate Similarity NPD5223 Approved
0.7917 Intermediate Similarity NPD5696 Approved
0.7907 Intermediate Similarity NPD4195 Approved
0.7895 Intermediate Similarity NPD4697 Phase 3
0.7889 Intermediate Similarity NPD5279 Phase 3
0.7857 Intermediate Similarity NPD5224 Approved
0.7857 Intermediate Similarity NPD5226 Approved
0.7857 Intermediate Similarity NPD5225 Approved
0.7857 Intermediate Similarity NPD4633 Approved
0.7857 Intermediate Similarity NPD5211 Phase 2
0.7857 Intermediate Similarity NPD6942 Approved
0.7857 Intermediate Similarity NPD7339 Approved
0.7849 Intermediate Similarity NPD5281 Approved
0.7849 Intermediate Similarity NPD5284 Approved
0.7791 Intermediate Similarity NPD3617 Approved
0.7789 Intermediate Similarity NPD5695 Phase 3
0.7778 Intermediate Similarity NPD4754 Approved
0.7778 Intermediate Similarity NPD5174 Approved
0.7778 Intermediate Similarity NPD5175 Approved
0.7738 Intermediate Similarity NPD4785 Approved
0.7738 Intermediate Similarity NPD4784 Approved
0.7711 Intermediate Similarity NPD4243 Approved
0.7708 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD5221 Approved
0.7708 Intermediate Similarity NPD5222 Approved
0.77 Intermediate Similarity NPD5141 Approved
0.7692 Intermediate Similarity NPD5330 Approved
0.7692 Intermediate Similarity NPD7146 Approved
0.7692 Intermediate Similarity NPD6684 Approved
0.7692 Intermediate Similarity NPD6098 Approved
0.7692 Intermediate Similarity NPD6409 Approved
0.7692 Intermediate Similarity NPD7521 Approved
0.7692 Intermediate Similarity NPD7334 Approved
0.767 Intermediate Similarity NPD4634 Approved
0.7629 Intermediate Similarity NPD5173 Approved
0.7624 Intermediate Similarity NPD6675 Approved
0.7624 Intermediate Similarity NPD5739 Approved
0.7624 Intermediate Similarity NPD7128 Approved
0.7624 Intermediate Similarity NPD4767 Approved
0.7624 Intermediate Similarity NPD4768 Approved
0.7624 Intermediate Similarity NPD6402 Approved
0.7614 Intermediate Similarity NPD4748 Discontinued
0.7609 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7579 Intermediate Similarity NPD5133 Approved
0.7573 Intermediate Similarity NPD6373 Approved
0.7573 Intermediate Similarity NPD6372 Approved
0.7553 Intermediate Similarity NPD4096 Approved
0.7549 Intermediate Similarity NPD5701 Approved
0.7549 Intermediate Similarity NPD5697 Approved
0.7527 Intermediate Similarity NPD6903 Approved
0.7527 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7527 Intermediate Similarity NPD4518 Approved
0.7527 Intermediate Similarity NPD5208 Approved
0.7476 Intermediate Similarity NPD6011 Approved
0.7476 Intermediate Similarity NPD6881 Approved
0.7476 Intermediate Similarity NPD6899 Approved
0.7476 Intermediate Similarity NPD4729 Approved
0.7476 Intermediate Similarity NPD5128 Approved
0.7476 Intermediate Similarity NPD7320 Approved
0.7476 Intermediate Similarity NPD4730 Approved
0.747 Intermediate Similarity NPD3698 Phase 2
0.7447 Intermediate Similarity NPD6673 Approved
0.7447 Intermediate Similarity NPD6080 Approved
0.7447 Intermediate Similarity NPD6904 Approved
0.7442 Intermediate Similarity NPD5275 Approved
0.7442 Intermediate Similarity NPD4190 Phase 3
0.7429 Intermediate Similarity NPD6650 Approved
0.7429 Intermediate Similarity NPD6649 Approved
0.7423 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD7525 Registered
0.7416 Intermediate Similarity NPD4695 Discontinued
0.7407 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7404 Intermediate Similarity NPD6012 Approved
0.7404 Intermediate Similarity NPD6013 Approved
0.7404 Intermediate Similarity NPD6014 Approved
0.7391 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD4244 Approved
0.7381 Intermediate Similarity NPD4245 Approved
0.7381 Intermediate Similarity NPD4747 Approved
0.7368 Intermediate Similarity NPD5207 Approved
0.734 Intermediate Similarity NPD6672 Approved
0.734 Intermediate Similarity NPD5737 Approved
0.7333 Intermediate Similarity NPD5135 Approved
0.7333 Intermediate Similarity NPD7290 Approved
0.7333 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD5249 Phase 3
0.7333 Intermediate Similarity NPD5250 Approved
0.7333 Intermediate Similarity NPD5169 Approved
0.7333 Intermediate Similarity NPD7102 Approved
0.7333 Intermediate Similarity NPD6883 Approved
0.7333 Intermediate Similarity NPD5247 Approved
0.7333 Intermediate Similarity NPD5251 Approved
0.7333 Intermediate Similarity NPD5369 Approved
0.7333 Intermediate Similarity NPD5248 Approved
0.7327 Intermediate Similarity NPD5091 Approved
0.7326 Intermediate Similarity NPD6924 Approved
0.7326 Intermediate Similarity NPD6926 Approved
0.732 Intermediate Similarity NPD6001 Approved
0.7312 Intermediate Similarity NPD4623 Approved
0.7312 Intermediate Similarity NPD4519 Discontinued
0.7294 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD5693 Phase 1
0.7292 Intermediate Similarity NPD7515 Phase 2
0.7282 Intermediate Similarity NPD6008 Approved
0.7264 Intermediate Similarity NPD5215 Approved
0.7264 Intermediate Similarity NPD5127 Approved
0.7264 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD5217 Approved
0.7264 Intermediate Similarity NPD6869 Approved
0.7264 Intermediate Similarity NPD5216 Approved
0.7264 Intermediate Similarity NPD6847 Approved
0.7264 Intermediate Similarity NPD8130 Phase 1
0.7264 Intermediate Similarity NPD6617 Approved
0.7262 Intermediate Similarity NPD4137 Phase 3
0.7262 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD7115 Discovery
0.7196 Intermediate Similarity NPD8297 Approved
0.7196 Intermediate Similarity NPD6882 Approved
0.7188 Intermediate Similarity NPD5692 Phase 3
0.7176 Intermediate Similarity NPD4691 Approved
0.7176 Intermediate Similarity NPD4789 Approved
0.7159 Intermediate Similarity NPD6933 Approved
0.7143 Intermediate Similarity NPD5360 Phase 3
0.7143 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3621 Clinical (unspecified phase)
0.713 Intermediate Similarity NPD4632 Approved
0.7113 Intermediate Similarity NPD6050 Approved
0.7113 Intermediate Similarity NPD5694 Approved
0.7065 Intermediate Similarity NPD4270 Approved
0.7065 Intermediate Similarity NPD4269 Approved
0.7064 Intermediate Similarity NPD5167 Approved
0.7054 Intermediate Similarity NPD6059 Approved
0.7054 Intermediate Similarity NPD6319 Approved
0.7054 Intermediate Similarity NPD6054 Approved
0.7048 Intermediate Similarity NPD6412 Phase 2
0.7045 Intermediate Similarity NPD3702 Approved
0.7 Intermediate Similarity NPD6274 Approved
0.6991 Remote Similarity NPD6016 Approved
0.6991 Remote Similarity NPD6015 Approved
0.6981 Remote Similarity NPD5168 Approved
0.697 Remote Similarity NPD7748 Approved
0.6964 Remote Similarity NPD4522 Approved
0.6939 Remote Similarity NPD8035 Phase 2
0.6939 Remote Similarity NPD8034 Phase 2
0.6937 Remote Similarity NPD6009 Approved
0.6937 Remote Similarity NPD6317 Approved
0.6932 Remote Similarity NPD5733 Approved
0.6932 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6932 Remote Similarity NPD4058 Approved
0.6932 Remote Similarity NPD4687 Approved
0.6931 Remote Similarity NPD7902 Approved
0.693 Remote Similarity NPD6370 Approved
0.693 Remote Similarity NPD5988 Approved
0.6907 Remote Similarity NPD7285 Clinical (unspecified phase)
0.69 Remote Similarity NPD5654 Approved
0.6897 Remote Similarity NPD7151 Approved
0.6897 Remote Similarity NPD7152 Approved
0.6897 Remote Similarity NPD7150 Approved
0.6897 Remote Similarity NPD5276 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data